Michael Scolaro

Michael Scolaro

Aug 25, 2017

Group 6 Copy 159
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Can cockroaches help us cure tularemia?

Tularemia is a deadly disease caused by the bacterium Francisella tularensis (Ft). This bacterium is also a...

How do you know a surgeon in training is ready to operate independently?

I am trying to find a cheap, easy and reliable way to grade the skill of surgeons in training. Experts can judge...

The Dogs of Chernobyl Research Initiative

The Chernobyl disaster site has hundreds of feral dogs that are in need of care. A team of students from the...

Backer Badge Funded